From Wikipedia: A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original "innovator" products, and can be manufactured when the original product's patent expires.
More information on FDA-approved biosimilar products is available through the link.
Note: at this time, due to prioritization, we will de-prioritize adding literature directly related to the evaluation of biosimilars (e.g., an RCT that compares the original product to a biosimilar). If this is content that you desire to see on HemOnc.org, please let us know through the contact email.
Pages in category "Biosimilars"
The following 18 pages are in this category, out of 18 total.